Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody
Abstract Brain positron emission tomography (PET) imaging with radiolabelled proteins is an emerging concept that potentially enables visualization of unique molecular targets in the brain. However, the pharmacokinetics and protein radiolabelling methods remain challenging. Here, we report the perfo...
Guardado en:
Autores principales: | Takahiro Morito, Ryuichi Harada, Ren Iwata, Yiqing Du, Nobuyuki Okamura, Yukitsuka Kudo, Kazuhiko Yanai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ed6b02705444b138a1da6dafa57c210 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
por: Javad Garousi, et al.
Publicado: (2017) -
Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
por: Jonas Persson, et al.
Publicado: (2021) -
The Impact of Glycerol on an Affibody Conformation and Its Correlation to Chemical Degradation
por: Ingrid Ramm, et al.
Publicado: (2021) -
Affibody Functionalized Beads for the Highly Sensitive Detection of Cancer Cell-Derived Exosomes
por: Nima Sayyadi, et al.
Publicado: (2021) - Journal of fluorine chemistry